These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 27853362)
21. A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease. Kern DM; Williams SA; Tunceli O; Wessman C; Zhou S; Pethick N; Elhefni H; Trudo F Int J Chron Obstruct Pulmon Dis; 2014; 9():775-83. PubMed ID: 25071369 [TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management. Roberts M; Mapel D; Petersen H; Blanchette C; Ramachandran S J Med Econ; 2011; 14(6):769-76. PubMed ID: 21942463 [TBL] [Abstract][Full Text] [Related]
23. The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials. Eriksson G; Calverley PM; Jenkins CR; Anzueto AR; Make BJ; Lindberg M; Fagerås M; Postma DS Int J Chron Obstruct Pulmon Dis; 2017; 12():1457-1468. PubMed ID: 28553098 [TBL] [Abstract][Full Text] [Related]
24. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Nannini L; Cates CJ; Lasserson TJ; Poole P Cochrane Database Syst Rev; 2004; (3):CD003794. PubMed ID: 15266502 [TBL] [Abstract][Full Text] [Related]
25. Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis. Tang B; Wang J; Luo LL; Li QG; Huang D Int J Chron Obstruct Pulmon Dis; 2019; 14():757-766. PubMed ID: 31015757 [TBL] [Abstract][Full Text] [Related]
26. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Nannini L; Lasserson TJ; Poole P Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994 [TBL] [Abstract][Full Text] [Related]
27. Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD. Calverley PM; Eriksson G; Jenkins CR; Anzueto AR; Make BJ; Persson A; Fagerås M; Postma DS Int J Chron Obstruct Pulmon Dis; 2017; 12():13-25. PubMed ID: 28031707 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of a Therapeutic Interchange from Fluticasone/Salmeterol to Mometasone/Formoterol in Patients with Chronic Obstructive Pulmonary Disease. Yip E; Karimi S; Pien LT J Manag Care Spec Pharm; 2016 Apr; 22(4):316-23. PubMed ID: 27023685 [TBL] [Abstract][Full Text] [Related]
29. Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA. Stanford RH; Parker ED; Reinsch TK; Buikema AR; Blauer-Peterson C Respir Med; 2019 Apr; 150():1-7. PubMed ID: 30961933 [TBL] [Abstract][Full Text] [Related]
30. Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment. Davis JR; Kern DM; Williams SA; Tunceli O; Wu B; Hollis S; Strange C; Trudo F J Manag Care Spec Pharm; 2016 Mar; 22(3):293-304. PubMed ID: 27003559 [TBL] [Abstract][Full Text] [Related]
31. Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review. Solidoro P; Patrucco F; Bagnasco D Expert Rev Respir Med; 2019 Nov; 13(11):1087-1094. PubMed ID: 31498714 [No Abstract] [Full Text] [Related]
32. Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD. Muiser S; Imkamp K; Seigers D; Halbersma NJ; Vonk JM; Luijk BHD; Braunstahl GJ; van den Berg JW; Kroesen BJ; Kocks JWH; Heijink IH; Reddel HK; Kerstjens HAM; van den Berge M Thorax; 2023 May; 78(5):451-458. PubMed ID: 36725331 [TBL] [Abstract][Full Text] [Related]
33. Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD. Gao J; Pleasants RA Int J Chron Obstruct Pulmon Dis; 2015; 10():775-89. PubMed ID: 25926729 [TBL] [Abstract][Full Text] [Related]
34. Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations. Papi A; Mansur AH; Pertseva T; Kaiser K; McIver T; Grothe B; Dissanayake S J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):346-61. PubMed ID: 27104231 [TBL] [Abstract][Full Text] [Related]
35. Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety. Suissa S; Dell'Aniello S; Ernst P Respir Med; 2021; 189():106645. PubMed ID: 34757243 [TBL] [Abstract][Full Text] [Related]
36. Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD. Kerwin EM; Siler TM; Arora S; Darken P; Rose E; Reisner C Int J Chron Obstruct Pulmon Dis; 2018; 13():1483-1494. PubMed ID: 29773947 [TBL] [Abstract][Full Text] [Related]
37. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176 [TBL] [Abstract][Full Text] [Related]
38. Budesonide + formoterol delivered via Spiromax Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829 [TBL] [Abstract][Full Text] [Related]
39. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany. Aballéa S; Cure S; Vogelmeier C; Wirén A Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555 [TBL] [Abstract][Full Text] [Related]
40. Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success. Müllerová H; Chan JSK; Heatley H; Carter V; Townend J; Skinner D; Franzén S; Marshall J; Price D Int J Chron Obstruct Pulmon Dis; 2024; 19():1153-1166. PubMed ID: 38813078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]